Spe­cial­ty phar­ma play­er snaps up Aca­cia and its 2 drugs for a handy $100M

When Cam­bridge, UK-based Aca­cia Phar­ma fi­nal­ly scored an FDA ap­proval for its res­cue treat­ment of post­op­er­a­tive nau­sea and vom­it­ing, it was the cul­mi­na­tion of a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER